Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Novelion Therapeutics
Novelion Therapeutics
(NVLN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lecithin
blindness
,
retinitis pigmentosa
,
retinitis
,
leber congenital amaurosis
Albumin
non-small-cell lung carcinoma
,
lung neoplasms
Aglatimagene besadenovec
prostatic hyperplasia
,
hyperplasia
,
lower urinary tract symptoms
LEMUTEPORFIN
prostatic hyperplasia
,
hyperplasia
,
lower urinary tract symptoms
Tariquidar
breast neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
Zuretinol acetate
retinitis pigmentosa
,
retinitis
,
blindness
,
leber congenital amaurosis
Retinol
retinitis pigmentosa
,
retinitis
,
blindness
,
leber congenital amaurosis
Pdt
prostatic hyperplasia
,
hyperplasia
,
melanoma
,
lower urinary tract symptoms
,
pathologic neovascularization
,
carcinoma
,
basal cell carcinoma
,
syndrome
,
basal cell nevus syndrome
,
basal cell neoplasms
,
macular degeneration
,
choroidal neovascularization
Nvb
non-small-cell lung carcinoma
,
lung neoplasms
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use